In this month’s Clinical Considerations, we learn from a new study that laser treatment following isotretinoin therapy can possibly be initiated sooner than we thought; researchers have shown microwave technology may reduce underarm odor, and glean guidance for diagnosing mycosis fungoides.
Derm NPs and Pas
This month, our clinical considerations include articles on the role of the microbe in acne, data around a topical agent to treat tinea pedis, and insights on sebum interacts with airborne pollution.
This month, we take a look at a treatment approach to hidradenitis suppurativa, the impact of atopic dermatitis on pediatric patients and a way to prevent mycosis fungoides progression.
In this month's Clinical Considerations, we look at handling the difficult patient, how to improve our diagnostic skills and the latest psoriasis drug approval.
This month we’re looking at some allergy guideline recommendations, discuss whether or not ‘natural’ soap is milder and novel immunomodulaters.
In our February Clinical Considerations, we take a look at treatment options for a few common skin disorders.
This month, we take a look at when to use biologics, advances in pediatric Atopic Dermatitis (AD), and how Trump’s presidency might impact dermatology.
Dermatology’s leaders share perspectives on how the new Administration may impact medicine.
In this month's Clinical Considerations, we take a look at AD and bullying, whether or not derms are doing enough for psoriasis patients, and the potential of Epicutaneous immunotherapy.
One dermatologist describes his considerations for choosing a biologic to treat a patient with moderate-to-severe psoriasis, baseline assessments, and follow-up approach.